Is it time to rethink checkpoint blockade therapy in non-Hodgkin lymphoma?
Affiliation
Division of Cancer Sciences, University of Manchester, Manchester, UK.Issue Date
2020
Metadata
Show full item recordCitation
Phillips EH, Illidge TM. Is it time to rethink checkpoint blockade therapy in non-Hodgkin lymphoma? Br J Haematol. 2020.Journal
British Journal of HaematologyDOI
10.1111/bjh.16854PubMed ID
32557549Additional Links
https://dx.doi.org/10.1111/bjh.16854Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1111/bjh.16854